Japan Medical Dynamic Marketing (TSE:7600) Total Stockholders Equity: 円25,400 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:7600 Japan Medical Dynamic Marketing Inc TSE:7600
72 GF Score
Price 円637.00
GF Value 円607.17
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Japan Medical Dynamic Marketing Total Stockholders Equity?

Japan Medical Dynamic Marketing TSE:7600 +3.24% 72 Total Stockholders Equity is 円25,400 Mil as of Mar. 2026. GuruFocus rates TSE:7600 with a GF Score™ of 72/100 and a GF Value™ of 円607.17 (Fairly Valued). The stock has 6 warning signs investors should review.

Japan Medical Dynamic Marketing's Total Stockholders Equity for the quarter that ended in Mar. 2026 was 円25,400 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Japan Medical Dynamic Marketing's Book Value per Share for the quarter that ended in Mar. 2026 was 円963.80. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Japan Medical Dynamic Marketing's Debt-to-Equity for the quarter that ended in Mar. 2026 was 0.23.


Japan Medical Dynamic Marketing  (TSE:7600) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Japan Medical Dynamic Marketing's Book Value per Share for the quarter that ended in Mar. 2026 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Japan Medical Dynamic Marketing's Debt-to-Equity for the quarter that ended in Mar. 2026 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Japan Medical Dynamic Marketing Total Stockholders Equity Related Terms


Japan Medical Dynamic Marketing Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Japan Medical Dynamic Marketing's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Japan Medical Dynamic Marketing Total Stockholders Equity Chart

Japan Medical Dynamic Marketing Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21,386.44 23,161.63 25,511.32 24,679.26 25,399.96

Japan Medical Dynamic Marketing Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23,955.06 24,320.02 25,123.39 25,399.96 24,805.80
TSE:7600
72GF Score
Japan Medical Dynamic Marketing Inc TSE:7600
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of 円25,400 Mil mean?
Japan Medical Dynamic Marketing (TSE:7600) has a Total Stockholders Equity of 円25,400 Mil as of Mar. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Japan Medical Dynamic Marketing and its competitors.
Is Japan Medical Dynamic Marketing's Total Stockholders Equity too high?
Japan Medical Dynamic Marketing's current Total Stockholders Equity is 円25,400 Mil. Overall, Japan Medical Dynamic Marketing has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Japan Medical Dynamic Marketing's Total Stockholders Equity compare to ABT and SYK?
Japan Medical Dynamic Marketing's Total Stockholders Equity of 円25,400 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Medical Devices & Instruments company?
A good Total Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Japan Medical Dynamic Marketing and its competitors. Japan Medical Dynamic Marketing's current Total Stockholders Equity is 円25,400 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Japan Medical Dynamic Marketing stock overvalued right now?
Based on GuruFocus' analysis, Japan Medical Dynamic Marketing (TSE:7600) is currently considered Fairly Valued. The stock's GF Value™ is 円607.17, compared to a current price of 円637.00 — trading 4.9% above its estimated fair value. The current Total Stockholders Equity is 円25,400 Mil. Japan Medical Dynamic Marketing's overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Japan Medical Dynamic Marketing (TSE:7600), the current Total Stockholders Equity is 円25,400 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Japan Medical Dynamic Marketing (TSE:7600) Overvalued in 2026?

Based on GuruFocus' analysis, Japan Medical Dynamic Marketing stock appears to be overvalued. The current stock price of 円637.00 is trading 4.9% above its estimated GF Value™ of 円607.17. GuruFocus considers Japan Medical Dynamic Marketing to be Fairly Valued.

Key valuation signals for TSE:7600:

  • Total Stockholders Equity: 円25,400 Mil
  • GF Value™: 円607.17 vs. price of 円637.00 (4.9% above fair value)
  • GF Score™: 72/100 with 6 warning signs

No single metric tells the full story. See the TSE:7600 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Japan Medical Dynamic Marketing Business Description

Other Exchanges JMDMF:USA
Address 12-2, Ichigayadaimachi, Shinjuku-ku, Tokyo, JPN, 162-0066
Japan Medical Dynamic Marketing Inc is a Japan-based medical equipment manufacturer. The company is engaged in the development and sale of advanced medical devices. Products offered by the company include trauma devices, joint prostheses, spinal fixation devices, and artificial bone fillers. It caters its products to medical professionals and major hospitals throughout Japan. The company is also engaged in the import and sale of medical devices.
72GF Score

Get the complete analysis for TSE:7600

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円637.00
Price
円607.17
GF Value